Cancer Tubulin Inhibitors Market: Advancements, Challenges, and Future Prospects, 2023-2032
Cancer Tubulin Inhibitors are a class of therapeutic agents that target the tubulin protein, a...
Sa. Nov 16th, 2024
Cancer Tubulin Inhibitors are a class of therapeutic agents that target the tubulin protein, a...